Skip to main content
Premium Trial:

Request an Annual Quote

N-of-One Inks Deal With NeoGenomics to Interpret Cancer Dx Tests

NEW YORK (GenomeWeb) – Bioinformatics firm N-of-One today announced an agreement with NeoGenomics to interpret the results of tests performed by the cancer genetics diagnostics firm.

Under the agreement, Lexington, Mass.-based N-of-One will provide clinical and interpretive evidence for NeoGenomics' NeoType solid tumor NGS tests, which report the most common and actionable genomic abnormalities in various subtypes of solid tumors.

Financial terms of the agreement were not disclosed.

"NeoGenomics selected N-of-One because of their oncology domain expertise and the flexible and efficient approach to tailoring their interpretation to meet our needs," NeoGenomics Chief Medical Officer Maher Albitar of said in a statement.

Fort Meyers, Fla.-based NeoGenomics is a high-complexity CLIA-certified clinical laboratory that provides a series of cancer testing services, including cytogenetics, FISH, flow cytometry, immunohistochemistry, and molecular genetic testing.

N-of-One provides highly scalable, cost-effective, patient-specific clinical interpretation for oncology testing.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.